Although the exact molecular bases of this symptom are still unknown, recent studies have demonstrated the presence of alterations in adipose tissue function in HD patients [78], while reduced circulating levels of insulin-like growth factor (IGF-1) have been found in patients and in R6/2 mice [79]. The gene discussed is IGF1; the disease is Huntington disease.